Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019

Table 1

The ratio of pathogens in cancer patients complicated with BSI.

Pathogen	Number of isolates	Composition ratio (%)
Escherichia coli	697	29.21
Coagulase-negative staphylococci	387	16.22
Klebsiella pneumoniae	318	13.33
Staphylococcus aureus	139	5.83
Pseudomonas aeruginosa	94	3.94
Enterobacter cloacae	88	3.69
Enterococcus faecalis	77	3.23
Enterococcus faecium	70	2.93
Candida albicans	46	1.93
Klebsiella oxytoca	40	1.68
Acinetobacter baumannii	26	1.09
Stenotrophomonas maltophilia	25	1.05
Streptococcus anginosus	25	1.05
Serratia marcescens	21	0.88
Streptococcus mitis	19	0.80
Enterobacter aerogenes	17	0.71
Proteus mirabilis	17	0.71
Streptococcus intermedius	14	0.59
Streptococcus constellatus	13	0.54
Citrobacter freundii	13	0.54
Candida parapsilosis	12	0.50
Enterococcus gallinarum	12	0.50
Streptococcus pneumoniae	12	0.50
Burkholderia cepacia	10	0.42
Salmonella sp.	30	1.26
Candida glabrata	9	0.38
Aeromonas hydrophila	9	0.38
Enterococcus avium	9	0.38
Morganella morganii	8	0.34
Candida tropicalis	8	0.34
Streptococcus pyogenes	6	0.25
Acinetobacter lwoffii	5	0.21
Candida famata	5	0.21
Pantoea agglomerans	5	0.21
Acinetobacter junii	5	0.21
Streptococcus sanguinis	5	0.21
Other bacteria	90	3.77
Total	2386	100.00